These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6202294)

  • 1. The antiheparin effect of a heparinoid, pentosan polysulphate. Investigation of a mechanism.
    Scully MF; Kakkar VV
    Biochem J; 1984 Mar; 218(3):657-65. PubMed ID: 6202294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
    Scully MF; Kakkar VV
    Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant and antiheparin activities of a pentosan polysulphate.
    Scully MF; Weerasinghe KM; Ellis V; Djazaeri B; Kakkar VV
    Thromb Res; 1983 Jul; 31(1):87-97. PubMed ID: 6193602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of heparin cofactor II as the principal plasma cofactor for the antithrombin activity of pentosan polysulphate (SP54).
    Scully MF; Kakkar VV
    Thromb Res; 1984 Oct; 36(2):187-94. PubMed ID: 6209821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between the effect of pentosan polysulphate heparin and antithrombin III injections in antithrombin III deficient patients.
    Fischer AM; Dautzenberg MD; Aurousseau MH; Béguin S; Goudemand J; Hemker HC
    Thromb Res; 1985 Jan; 37(2):295-307. PubMed ID: 2579452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentosan polysulphate: activation of heparin cofactor II or antithrombin III according to molecular weight fractionation.
    Scully MF; Ellis V; Kakkar VV
    Thromb Res; 1986 Feb; 41(4):489-99. PubMed ID: 2421433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
    Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J
    Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.
    Ofosu FA; Sie P; Modi GJ; Fernandez F; Buchanan MR; Blajchman MA; Boneu B; Hirsh J
    Biochem J; 1987 Apr; 243(2):579-88. PubMed ID: 2443128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
    Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharides.
    Freyssinet JM; Wiesel ML; Grunebaum L; Pereillo JM; Gauchy J; Schuhler S; Freund G; Cazenave JP
    Biochem J; 1989 Jul; 261(2):341-8. PubMed ID: 2476115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
    Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B
    Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a sulfated polysaccharide on antithrombin III.
    Czapek EE; Kwaan HC; Szczecinski M
    J Lab Clin Med; 1980 Jun; 95(6):783-90. PubMed ID: 6155418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the lipolytic and anticoagulative properties of heparin and pentosan polysulphate in the thoroughbred horse.
    Orme CE; Harris RC
    Acta Physiol Scand; 1997 Feb; 159(2):179-85. PubMed ID: 9055947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
    Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant activities of a pentosane polysulphate: comparison with standard heparin and a fraction of low molecular weight heparin.
    Soria C; Soria J; Ryckewaert JJ; Holmer E; Caen JP
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):455-63. PubMed ID: 6160640
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of pentosan polysulphate, standard heparin and related compounds on protein kinase C activity.
    Herbert JM; Maffrand JP
    Biochim Biophys Acta; 1991 Feb; 1091(3):432-41. PubMed ID: 1705825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant activities of pentosan polysulphate (Hémoclar) due to release of hepatic triglyceride lipase (HTGL).
    Barrowcliffe TW; Gray E; Merton RE; Dawes J; Jennings CA; Hubbard AR; Thomas DP
    Thromb Haemost; 1986 Oct; 56(2):202-6. PubMed ID: 2433786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of antithrombin III isoforms by heparan sulphate glycosaminoglycans and other sulphated polysaccharides.
    Carlson TH; Kolman MR; Piepkorn M
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):474-80. PubMed ID: 8589216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of the inhibitory site(s) of pentosan polysulphate in blood coagulation.
    Wagenvoord R; Hendrix H; Soria C; Hemker HC
    Thromb Haemost; 1988 Oct; 60(2):220-5. PubMed ID: 2464199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.